* Radius Health Inc RDUS.OQ RDUS.O is expected to show a
fall
in quarterly revenue when it reports results on May 5.
* The Boston Massachusetts-based company is expected to
report a
8.8% decrease in revenue to $51.293 million from $56.26 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Radius Health Inc
is for
a loss of 21 cents per share. For the same quarter last year,
the company reported a loss of 31 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 5
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 11.5%
in the last three months.
* Wall Street's median 12-month price target for Radius
Health Inc
is $9.5, above its last closing price of $6.94.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 -0.16 -0.18 -0.33 Missed -85
Sep. 30 2021 -0.25 -0.24 -0.47 Missed -97.5
Jun. 30 2021 -0.34 -0.34 -0.35 Missed -4.4
Mar. 31 2021 -0.50 -0.41 -0.31 Beat 24.5
Dec. -0.28 -0.42 -0.46 Missed -10.4
31 2020
Sep. 30 2020 -0.11 -0.21 -0.14 Beat 34.5
Jun. 30 2020 -0.75 -0.74 -0.95 Missed -27.7
Mar. 31 2020 -0.69 -0.68 -0.81 Missed -18.4
This summary was machine generated May 3 at 18:32 GMT. All
figures in US dollars unless otherwise stated